Patients may have had prior adjuvant treatment for pancreatic cancer; the last dose of chemotherapy must have been >  months prior to study entry; patients with prior radiotherapy are acceptable; it must be at least  months since administration of radiation therapy and all signs of toxicity must have abated
Prior use of chemotherapy, radiotherapy, and / or investigational agents for pancreatic cancer
Any prior radiotherapy or chemotherapy for pancreatic cancer
Previous systemic chemotherapy or radiation for pancreatic cancer is not allowed
Had prior systemic therapy for pancreatic cancer
No prior therapy for pancreatic cancer, including chemotherapy, radiation therapy, definitive surgery or investigational therapy
Any prior therapy (chemotherapy, radiation or surgery) for pancreatic adenocarcinoma other than biliary decompression
Prior radiotherapy for pancreatic cancer
Prior systemic therapy for pancreatic cancer
No prior treatment (chemotherapy, biological therapy, or radiotherapy) for resectable pancreatic cancer
A history of previous chemotherapy for pancreatic cancer or abdominal radiation therapy
Prior use of radiotherapy or investigational agents for pancreatic cancer
Prior radiation therapy for pancreatic cancer
Patients must have no history of previous chemotherapy for pancreatic cancer or any abdominal radiation therapy
Prior abdominal radiation therapy or prior chemotherapy for pancreatic cancer
No prior chemotherapy or radiation for pancreatic cancer
Patients who have had any prior therapy for pancreatic cancer
Patients must not have received prior surgery, radiation therapy, chemotherapy, targeted therapy, or any investigational therapy for pancreatic cancer
Prior chemotherapy or radiation for pancreatic cancer
Patients must have had no prior chemotherapy or radiation therapy for pancreatic cancer
Prior chemotherapy, targeted therapy, immunotherapy, or any clinical trials or radiotherapy for pancreatic cancer
Prior therapy such as chemotherapy or radiation therapy or anti-tumor experimental therapy for pancreatic cancer
Prior therapy with ?  systemic chemotherapy regimen for unresectable or metastatic pancreatic cancer or unwilling/unable to receive systemic chemotherapy
Prior treatment with chemotherapy or radiation for pancreatic cancer or prior treatment with radiation for other diagnoses to expected pancreatic cancer treatment fields.
Prior treatment with any chemotherapy for metastatic disease from pancreatic cancer
Any prior chemotherapy, targeted/biologic therapy, or radiation for treatment of the patient's pancreatic tumor
Any prior chemotherapy or radiation for treatment of the patients pancreatic tumor
Part B only: Prior therapy (including investigational agents) for pancreatic cancer
Prior treatment with chemotherapy or radiation for pancreatic cancer or prior treatment with radiation for other diagnoses to expected pancreatic cancer treatment fields.
Any prior treatment (chemotherapy, radiation) for pancreatic cancer
Patient must not have received prior chemotherapy or radiation for pancreatic cancer
Patient must not have received prior chemotherapy or radiation for pancreatic cancer and no exposure to systemic chemotherapy
Prior chemotherapy, immunotherapy or radiation for pancreatic cancer
Any prior radiotherapy, chemotherapy, surgery, or investigational therapy for adjuvant or metastatic pancreatic cancer
Any prior chemotherapy or radiation for treatment of the patients pancreatic tumor
Any prior systemic or investigational therapy for pancreatic cancer